MEDROXYPROGESTERONE ACETATE Reviews (MEDROXYPROGESTERONE ACETATE)Average Rating: 2.0 (2 Ratings)Filter ResultsCompare MEDROXYPROGESTERONE ACETATE with similar:
Type: Rx Drug
|
Results are sorted by Date added. Key to Ratings: 1=LOW (I would not recommend taking this medicine.) Page: 1 |
RATING | REASON | SIDE EFFECTS FOR MEDROXYPROGESTE | COMMENTS | SEX | AGE | DURATION/ DOSAGE | DATE ADDED |
1 | Painful periods | Irritable,tired,weight gain in 2 months,bad dreams,can not sleep through night.debating on taking 3 month treatment | F | 44 | 2 months 10 Mg | 4/29/2012 | 3 | To stop heavy bleeding and clots | I was prescribed this drug when i went to the ER to stop my heavy bleeding. and it stop the blood clots it stop the clots after the third day and i been taking them for 7 days now. But it haven't completely stopped it like i thought it would. Now i'm having bad cramps and light bleeding. I just want to stop bleeding altogether. And i think I will stop taking the medicine after tomorrow. | Drug has had little side effects on me. But ultimately i just wanted the bleeding to totally stop. | F | 35 | 7 days 10mg 1X O | 8/10/2011 |
MEDROXYPROGESTERONE ACETATE (MEDROXYPROGESTERONE ACETATE): Medroxyprogesterone is a type of female hormone (progestin). This medication is similar to the progesterone that your body naturally makes and is given to replace the hormone when your body is not making enough of it. This medication has several uses. In women who are not pregnant and not going through menopause, this medication is used to treat abnormal bleeding from the uterus and to restore normal menstrual periods in women who have stopped having them for several months (amenorrhea). Medroxyprogesterone is also used as part of combination hormone replacement therapy with estrogens to reduce menopause symptoms (e.g., hot flashes). Medroxyprogesterone is added to estrogen replacement therapy to reduce the risk of cancer of the uterus. This medication must not be used to test for pregnancy. FDA Approval Date: 1996-08-09 (Sources: U.S. Centers for Medicare Services, FDA)